dihexa peptide parkinson's Therapy | Memory & Cognition Revamping Parkinson's disease therapy using
Description
See when a daily $35 spray beats a shot and when the injection still wins
Risk of confounded data
W-DC and Y-DW edited and revised the manuscript
Chemoresistance towards EGFR inhibition by small molecule tyrosine kinase inhibitors such as gefitinib or erlotinib are common features in clinical trials
